Fewer TB patients in the Netherlands The key figures of the National Institute for Public Health and the Environment (RIVM) show that in 2017, the number of TB patients in the Netherlands fell below 800 TB patients for the first time
Hormone-disrupting effect methyl-, ethyl- and propylparaben still unclear RIVM has conducted literature research into the hormone-disrupting effects of the three most commonly used parabens (methyl-, ethyl- and propylparaben) and the exposure of consumers to these substa
Legislation on maximum permitted amount of synephrine in food supplements is desirable Harmful health effects of dietary supplements with high levels of synephrine, which are used to lose weight or improve sports performance, cannot be excluded.
RIVM develops a framework for a broader view of establishing food safety standards In Europe, strict requirements apply to food safety. Food safety standards are determined at international level.
Less meat and more tap water benefits health and the environment In the Netherlands, diets with a high environmental impact contain more meat and energy.
No further spread of polio virus after contamination employee The employee of a Dutch vaccine manufacturer, who was infected with the polio virus in early April, is no longer carrying the virus.
Blood analysis local residents confirms longtime exposure to PFOA The results of blood analysis show that measured blood values correspond well with the calculated values in an earlier study in 2016 on the emission of perfluorooctanoic acid (PFOA) by DuPont/Chemo
HPV vaccination not only protects against cervical cancer HPV vaccination against cervical cancer also appears to protect against other forms of cancer that can be caused by HPV.
More knowledge required about environmental effect of GenX More knowledge is required about the extent to which GenX substances accumulate in fish.
Meningococcal immunisation recommendations re-examined Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.